Abstract
Thiazoles are important heterocyclics exhibiting boundaryless biological activities, such as antibacterial, antifungal, anti-inflammatory, antitumor, antitubercular, antidiabetic, antiviral, and antioxidant. Substituents on a particular position of the thiazole ring affect the biological outcomes to a great extent. Therefore, researchers have synthesized compounds containing the thiazole ring with variable substituents as target structures, and evaluated their biological activities. The present review describes the biological importance of recently developed 2,4-disubstituted thiazole derivatives. Moreover, we have thrown light on various targets of 2,4-disubstituted thiazoles through which they induce biological effects, which will be helpful to those who are working on the design and structure–activity relationship of bioactive molecules.
Similar content being viewed by others
Abbreviations
- Akt:
-
A protein kinase B
- AMPA:
-
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor
- CAs:
-
carbonic anhydrases
- CDK7/9:
-
cyclin-dependent kinases 7/9
- COX-2:
-
cyclooxygenase-2
- DHFR:
-
dihydrofolate reductase
- 14α-DM:
-
14α-demethylase
- DNA:
-
deoxyribonucleic acid
- DPP IV:
-
dipeptidyl peptidase IV
- ED50 :
-
effective dose, 50 %
- Env protein:
-
envelope protein
- mtFabH:
-
Mycobacterium tuberculosis β-ketoacyl-acyl carrier protein synthase III encoded by FabH gene
- FOXM1:
-
forkhead box M1
- GABAA α2/α3:
-
γ-aminobutyric acid type A receptors containing α2/α3 subunits
- GGR:
-
glucagon receptor
- GI50 :
-
growth inhibition, 50 %
- GIP-R:
-
gastric inhibitory polypeptide receptor
- mGlu5:
-
metabotropic glutamate receptor subtype 5
- GPase:
-
glycogen phosphorylases
- HATs:
-
histone acetyltransferases
- HCV NS3/5A:
-
hepatitis C virus non-structural protein 3/5A
- HDACs:
-
histone deacetylases
- HIV:
-
human immunodeficiency virus
- 11β-HSD1:
-
11-β-hydroxysteroid dehydrogenase type 1
- HSV UL5/8/52:
-
Herpes simplex virus helicase-primase complex
- IKK β:
-
inhibitor of nuclear factor kappa-B kinase subunit beta
- IMPd:
-
inosine monophosphate dehydrogenase
- InhA:
-
enoyl–acyl carrier protein reductase encoded by inhA gene
- JAK1:
-
Janus kinase 1
- JUNV:
-
Junin virus
- KCNQ1:
-
potassium voltage-gated channel KQT-like subfamily member 1
- Kv7.1:
-
voltage-gated potassium channel
- LD50 :
-
lethal dose, 50 %
- MetAP:
-
methionine aminopeptidase
- MGIT:
-
mycobacterial growth indicator tube
- MG-MID:
-
mean-graph midpoint value
- MIC:
-
minimum inhibitory concentration
- MM2:
-
a molecular mechanics force field
- MycG B:
-
mycobacterial gyrase B
- NFκB:
-
nuclear factor kappa beta
- NMDAR:
-
N-methyl-D-aspartate receptor
- NO•:
-
nitric oxide radical
- Nrf2:
-
nuclear factor erythroid 2-related factor 2
- OH•:
-
hydroxyl radical
- PADs:
-
protein arginine deiminases
- PBP:
-
penicillin-binding protein
- PD50 :
-
protective dose, 50 %
- PDE4:
-
phosphodiesterase-4
- PGE2:
-
prostaglandin E2
- PI3 kinase:
-
phosphoinositide 3-kinase
- PIKfyve:
-
phosphatidylinositol 3-phosphate 5-kinase
- PPARγ:
-
peroxisome proliferator-activated receptors gamma
- PRMTs:
-
protein arginine methyl transferases
- PTPs:
-
protein tyrosine phosphatases
- ROO•:
-
alkyl peroxy radical
- RT RNase H:
-
reverse transcriptase-associated ribonuclease H
- SAR:
-
structure–activity relationship
- SGLT 2:
-
sodium glucose co-transporter 2
- SK channel:
-
small-conductance calcium-activated potassium channels
- SMT:
-
sterol 24-C-methyltransferase
- SphK1:
-
sphingosine kinase 1
- 23S rRNA-L11:
-
L11 binding domain of 23S ribosomal RNA
- TD50 :
-
toxic dose, 50 %
- TGI:
-
total growth inhibition
- TI value:
-
therapeutic index value
- TNF-α:
-
tumor necrosis factor alpha
- Topo II:
-
type II topoisomerases
- UDP Glmutase:
-
UDP-galactopyranosemutase
- WHO:
-
World Health Organization
References
Abdel-Wahab BF, Abdel-Aziz HA, Ahmed EM (2009) Synthesis and antimicrobial evaluation of 1-(benzofuran-2-yl)-4-nitro-3-arylbutan-1-ones and 3-(benzofuran-2-yl)-4,5-dihydro-5-aryl-1-[4-(aryl)-1,3-thiazol-2-yl]-1H-pyrazoles. Eur J Med Chem 44:2632–2635
Abdel-Wahab BF, Awad GEA, Badria FA (2011) Synthesis, antimicrobial, antioxidant, anti-hemolytic and cytotoxic evaluation of new imidazole-based heterocycles. Eur J Med Chem 46:1505–1511
Al-Balas Q, Anthony NG, Al-Jaidi B, Alnimr A, Abbott G, Brown AK, Taylor RC, Besra GS, McHugh TD, Gillespie SH, Johnston BF, Mackay SP, Coxon GD (2009) Identification of 2-aminothiazole-4-carboxylate derivatives active against M. tuberculosis H37Rv and the β-ketoacyl-ACP synthase mtFabH. PLoS ONE 4:e5617
Al-Omary FAM, Hassan GS, El-Messery SM, El-Subbagh HI (2012) Substituted thiazoles V. Synthesis and antitumor activity of novel thiazolo[2,3-b] quinazoline and pyrido[4,3-d]thiazolo[3,2-a]pyrimidine analogues. Eur J Med Chem 47:65–72
Amin KM, Rahman DEA, Al-Eryani YA (2008) Synthesis and preliminary evaluation of some substituted coumarins as anticonvulsant agents. Bioorg Med Chem 16:5377–5388
Andres JI, Garcia-Lopez MT, De las Heras FG, Mendez-Castrillon PP (1986) Synthesis of 2-(β-D-ribofuranosyl)thiazole-4-carboxamide 5′-phosphate isosteres. Nucleos Nucleot Nucl 5:423–429
Aridoss G, Amirthaganesan S, Kim MS, Jeong YT (2009) Synthesis, spectral and biological evaluation of some new thiazolidinones and thiazoles based on t-3-alkyl-r-2,c-6-diarylpiperidin-4-ones. Eur J Med Chem 44:4199–4210
Arora P, Narang R, Bhatia S, Nayak SK, Singh SK, Narasimhan B (2015) Synthesis, molecular docking and QSAR studies of 2, 4-disubstituted thiazoles as antimicrobial agents. J Appl Pharm Sci 5:028–042
Arshad A, Osman H, Bagley MC, Lam CK, Mohamad S, Zahariluddin ASM (2011) Synthesis and antimicrobial properties of some new thiazolyl coumarin derivatives. Eur J Med Chem 46:3788–3794
Azam F, Alkskas IA, Khokra SL, Prakash O (2009) Synthesis of some novel N4-(naphtha[1,2-d]thiazol-2-yl)semicarbazides as potential anticonvulsants. Eur J Med Chem 44:203–211
Ban M, Taguchi H, Katsushima T, Takahashi M, Shinoda K, Watanabe A, Tominaga T (1998) Novel antiallergic and antiinflammatory agents. Part I: synthesis and pharmacology of glycolic amide derivatives. Bioorg Med Chem 6:1069–1076
Barradas JS, Errea MI, D’Accorso NB, Sepulveda CS, Damonte EB (2011) Imidazo[2,1-b]thiazole carbohydrate derivatives: synthesis and antiviral activity against Junin virus, agent of Argentine hemorrhagic fever. Eur J Med Chem 46:259–264
Baruah PK, Dinsmore J, King AM, Salome C, De Ryck M, Kaminski R, Provins L, Kohn H (2012) Synthesis, anticonvulsant activity, and neuropathic pain-attenuating activity of N-benzyl 2-amino-2-(hetero)aromatic acetamides. Bioorg Med Chem 20:3551–3564
Basarab GS, Manchester JI, Bist S, Boriack-Sjodin PA, Dangel B, Illingworth R, Sherer BA, Sriram S, Uria-Nickelsen M, Eakin AE (2013) Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents. J Med Chem 56:8712–8735
Bekhit AA, Fahmy HTY, Rostom SAF, Bekhit AA (2010) Synthesis and biological evaluation of some thiazolylpyrazole derivatives as dual anti-inflammatory antimicrobial agents. Eur J Med Chem 45:6027–6038
Bellale E, Naik M, Varun VB, Ambady A, Narayan A, Ravishankar S, Ramachandran V, Kaur P, McLaughlin R, Whiteaker J, Morayya S, Guptha S, Sharma S, Raichurkar A, Awasthy D, Achar V, Vachaspati P, Bandodkar B, Panda M, Chatterji M (2014) Diarylthiazole: an antimycobacterial scaffold potentially targeting PrrB-PrrA two-component system. J Med Chem 57:6572–6582
Bharti SK, Nath G, Tilak R, Singh SK (2010) Synthesis, anti-bacterial and anti-fungal activities of some novel schiff bases containing 2,4-disubstituted thiazole ring. Eur J Med Chem 45:651–660
Bickston SJ, Snider KR, Kappus MR (2012) Tetomilast: new promise for phosphodiesterase-4 inhibitors?. Expert Opin Investig Drugs 21:1845–1849
Borelli C, Schaller M, Niewerth M, Nocker K, Baasner B, Berg D, Tiemann R, Tietjen K, Fugmann B, Lang-Fugmann S, Korting HC (2008) Modes of action of the new arylguanidine abafungin beyond interference with ergosterol biosynthesis and in vitro activity against medically important fungi. Chemotherapy 54:245–259
Carter JS, Rogier DJ, Graneto MJ, Seibert K, Koboldt CM, Zhang Y, Talley JJ (1999) Design and synthesis of sulfonyl substituted 4,5-diarylthiazoles as selective cyclooxygenase-2-inhibitors. Bioorg Med Chem Lett 9:1167–1170
Chakravarty PK, Fisher MH, Parsons WH, Tyagarajan S, Zhou B (2004) Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers. WO Patent 2004-094395 A2, filled 14 Apr 2004, issued 4 Nov 2004
Chaniyara R, Tala S, Chen C, Lee P, Kakadiya R, Dong H, Marvania B, Chen C, Chou T, Lee T, Shah A, Su T (2012) Synthesis and antitumor evaluation of novel benzo[d]pyrrolo[2,1-b]thiazole derivatives. Eur J Med Chem 53:28–40
Cheeseright T, Mackey M, Rose S, Vinter A (2006) Molecular field extrema as descriptors of biological activity: definition and validation. J Chem Inf Model 46:665–676
Cheruvallath ZS, Loweth CJ, Nutt RF, Rideout D, Semple JE, Wang J, Wu F, Mylvaganam S, Zhu H, Sun J (2008) Thiazole and thiadiazole inhibitors of tyrosine phosphatases. US Patent 2008-7381736 B2, filled 2 Sep 2005, issued 3 June 2008
Clare JJ, Tate SN, Nobbs M, Romanos MA (2000) Voltage-gated sodium channels as therapeutic targets. Drug Discov Today 5:506–520
Collins I, Moyes C, Davey WB, Rowley M, Bromidge FA, Quirk K, Atack JR, McKernan RM, Thompson SA, Wafford K, Dawson GR, Pike A, Sohal B, Tsou NN, Ball RG, Castro JL (2002) 3-Heteroaryl-2-pyridones: benzodiazepine site ligands with functional selectivity for α2/α3-subtypes of human GABA-A receptor-ion channels. J Med Chem 45:1887–1900
Cukurovali A, Yilmaz I, Gur S, Kazaz C (2006) Synthesis, antibacterial and antifungal activity of some new thiazolylhydrazone derivatives containing 3-substituted cyclobutane ring. Eur J Med Chem 41:201–207
Dawane BS, Konda SG, Mandawad GG, Shaikh BM (2010) Poly(ethylene glycol) (PEG-400) as an alternative reaction solvent for the synthesis of some new 1-(4-(4′-chlorophenyl)-2-thiazolyl)- 3-aryl-5-(2-butyl-4-chloro-1H-imidazol-5yl)-2-pyrazolines and their in vitro antimicrobial evaluation. Eur J Med Chem 45:387–392
Dawood KM, Abdel-Gawad H, Rageb EA, Ellithey RM, Mohamed HA (2006) Synthesis, anticonvulsant, and anti-inflammatory evaluation of some new benzotriazole and benzofuran-based heterocycles. Bioorg Med Chem 14:3672–3680
De S, Adhikari S, Tilak-Jain J, Menon VP, Devasagaym TP (2008) Antioxidant activity of an aminothiazole compound: possible mechanisms. Chem Biol Interact 173:215–223
Dykhuizen EC, May JF, Tongpenyai A, Kiessling LL (2008) Inhibitors of UDP-galactopyranose mutase thwart mycobacterial growth. J Am Chem Soc 130:6706–6707
Earle MF, Glazer RI (1983) Activity and metabolism of 2-β-D-ribofuranosylthiazole-4-carboxamide in human lymphoid tumor cells in culture. Cancer Res 43:133–137
Eguchi K, Ueda Y, Kanazawa K, Sunagawa M, Gotoh N (2007) The mode of action of 2-(thiazol-2-ylthio)-1 b-methylcarbapenems against Pseudomonas aeruginosa: the impact of outer membrane permeability and the contribution of MexAB-OprM efflux system. J Antibiot 60:129–135
El-Messery SM, Hassan GS, Al-Omary FAM, El-Subbagh HI (2012) Substituted thiazoles VI. Synthesis and antitumor activity of new 2-acetamido- and 2 or 3-propanamido-thiazole analogs. Eur J Med Chem 54:615–625
El-Sabbagh OI, Baraka MM, Ibrahim SM, Pannecouque C, Andrei G, Snoeck R, Balzarini J, Rashad AA (2009) Synthesis and antiviral activity of new pyrazole and thiazole derivatives. Eur J Med Chem 44:3746–3753
El-Subbagha HI, Hassan GS, El-Azabb AS, Abdel-Aziz AAM, Kadib AA, Al-Obaidb AM, Al-Shabanahe OA, Sayed-Ahmede MM (2011) Synthesis and anticonvulsant activity of some new thiazolo[3,2-a][1,3]diazepine, benzo[d]thiazolo[5,2 a][12,6]diazepine and benzo[d]oxazolo[5,2-a][12,6] diazepine analogues. Eur J Med Chem 46:5567–5572
Eswaran S, Adhikari AV, Pal NK, Chowdhury IH (2010) Design and synthesis of some new quinoline-3-carbohydrazone derivatives as potential antimycobacterial agents. Bioorg Med Chem Lett 20:1040–1044
Fallah-Tafti A, Foroumadi A, Tiwari R, Shirazi AN, Hangauer DG, Bu Y, Akbarzadeh T, Parang K, Shafiee A (2011) Thiazolyl N-benzyl-substituted acetamide derivatives: synthesis, Src kinase inhibitory and anticancer activities. Eur J Med Chem 46:4853–4858
Franchetti P, Cappellacci L, Pasqualini M, Petrelli R, Jayaprakasan V, Jayaram HN, Boyd DB, Jain MD, Grigantini M (2005) Synthesis, conformational analysis, and biological activity of new analogues of thiazole-4-carboxamide adenine dinucleotide (TAD) as IMP dehydrogenase inhibitors. Bioorg Med Chem 13:2045–2053
Fuji H, Urano E, Futahashi Y, Hamatake M, Tatsumi J, Hoshino T, Morikawa Y, Yamamoto N, Komano J (2009) Derivatives of 5-nitro-furan-2-carboxylic acid carbamoylmethyl ester inhibit RNase H activity associated with HIV-1 reverse transcriptase. J Med Chem 52:1380–1387
Fuxu Z, Yuli W, Guilong Z, Weiren X, Yiliang L, Meixiang Z, Lida T, Jianwu W (2009) Design, synthesis and anti-diabetic activities of thiazole-bearing compounds as dipeptidyl peptidase IV inhibitors. Chin J Org Chem 29:1236–1242
Gahtori P, Ghosh SK, Singh B, Singh UP, Bhat HR, Uppal A (2012) Synthesis, SAR and antibacterial activity of hybrid chloro, dichloro-phenylthiazolyl-s-triazines. Saudi Pharm J 20:35–43
Ganapathi K, Kulkarni KD (1953) Chemistry of the thiazoles. Part V. Fine structures and orientation. Proc Indian Acad Sci Sect A 38(1):45–57
Gartel AL (2013) Thiazole antibiotics siomycin A and thiostrepton inhibit the transcriptional activity of FOXM1. Front Oncol 3:1
Gemma S, Savini L, Altarelli M, Tripaldi P, Chiasserini L, Coccone SS, Kumar V, Camodeca C, Campiani G, Novellino E, Clarizio S, Delogu G, Butini S (2009) Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure–activity relationship studies. Bioorg Med Chem 17:6063–6072
Gentles RG, Grant-Young K, Hu S, Huang Y, Poss MA, Andres C, Fiedler T, Knox R, Lodge N, Weaver CD, Harden DG (2008) Initial SAR studies on apamin-displacing 2-aminothiazole blockers of calcium-activated small conductance potassium channels. Bioorg Med Chem Lett 18:5316–5319
Goldstein BM, Leary JF, Farley BA, Marquez VE, Levy PC, Rowley PT (1991) Induction of HL60 cell differentiation by tiazofurin and its analogues: characterization and efficacy. Blood 78:593–598
Gursoy E, Guzeldemirci NU (2007) Synthesis and primary cytotoxicity evaluation of new imidazo[2,1-b]thiazole derivatives. Eur J Med Chem 42:320–326
Guzeldemirci NU, Kucukbasmac O (2010) Synthesis and antimicrobial activity evaluation of new 1,2,4-triazoles and 1,3,4-thiadiazoles bearing imidazo[2,1-b]thiazole moiety. Eur J Med Chem 45:63–68
Hantzsch A, Weber JH (1887) Ueber verbindungen des thiazols (pyridins der thiophenreihe) [About the thiazole compounds (pyridine of thiophene)]. Ber Dtsch Chem Ges 20:3118–3132
Hassan GS, El-Messery SM, Al-Omary FA, Al-Rashood ST, Shabayek MI, Abulfadl YS, Habib el-SE, El-Hallouty SM, Fayad W, Mohamed KM, El-Menshawi BS, El-Subbagh HI (2013) Nonclassicalantifolates, Part 4. 5-(2-aminothiazol-4-yl)-4-phenyl-4H-1,2,4-Triazole-3-thiols as a new class of DHFR inhibitors: synthesis, biological evaluation and molecular modeling study. Eur J Med Chem 66:135–145
Hassan GS, El-Messery SM, Al-Omary FAM, El-Subbagh HI (2012) Substituted thiazoles VII. Synthesis and antitumor activity of certain 2-(substituted amino)-4-phenyl-1,3-thiazole analogs. Bioorg Med Chem Lett 22:6318–6323
Hayakawa M, Kaizawa H, Kawaguchi K, Ishikawa N, Koizumi T, Ohishi T, Yamano M, Okada M, Ohta M, Tsukamoto S, Raynaud FI, Waterfield MD, Parker P, Workman P (2007) Synthesis and biological evaluation of imidazo[1,2-a]pyridine derivatives as novel PI3 kinase p110α inhibitors. Bioorg Med Chem 15:403–412
Helal MHM, Salem MA, El-Gaby MSA, Aljahdali M (2013) Synthesis and biological evaluation of some novel thiazole compounds as potential anti-inflammatory agents. Eur J Med Chem 65:517–526
Huang T, Xue CB, Wang A, Kong L, Ye HF, Yao W, Rodgers JD, Shepard S, Wang H, Shao L, Li H-Y, Li Q (2011) Piperidin-4-yl azetidine derivatives as jak1 inhibitors. US Patent 2011-112662 A1, filled 9 Mar 2011, issued 15 Sep 2011
Jaishree V, Ramdas N, Sachin J, Ramesh B (2012) In vitro antioxidant properties of new thiazole derivatives. J Saudi Chem Soc 16:371–376
Jeankumar VU, Renuka J, Santosh P, Soni V, Sridevi JP, Suryadevara P, Yogeeswari P, Sriram D (2013) Thiazole–aminopiperidine hybrid analogues: design and synthesis of novel M. tuberculosis GyrB inhibitors. Eur J Med Chem 70:143–153
Jinbo Y, Konda H, Taguchi M, Inoue Y, Sakamoto F, Tsukamoto G (1994) Synthesis and antibacterial activity of thiazolopyrazine-incorporated tetracyclic quinolone antibacterial agents. J Med Chem 37:2791–2796
Kanno T, Tanaka K, Yanagisawa Y, Yasutake K, Hadano S, Yoshii F, Hirayama N, Iked J-E (2012) A novel small molecule, N-(4-(2-pyridyl)(1,3-thiazol-2-yl))-2-(2,4,6-trimethylphenoxy) acetamide, selectively protects against oxidative stress-induced cell death by activating the Nrf2-ARE pathway: therapeutic implications for ALS. Free Radic Biol Med 53:2028–2042
Karegoudar P, Karthikeyan MS, Prasad DJ, Mahalinga M, Holla BS, Kumari NS (2008) Synthesis of some novel 2,4-disubstituted thiazoles as possible antimicrobial agents. Eur J Med Chem 43:261–267
Karthikeyan MP (2009) Synthesis, analgesic anti-inflammatory and antimicrobial studies of 2,4-dichloro-5-fluorophenyl containing thiazolotriazoles. Eur J Med Chem 44:827–833
Karuvalam RP, Haridas KR, Nayak SK, Rowb TNG, Rajeesh P, Rishikesan R, Kumari S (2012) Design, synthesis of some new (2-aminothiazol-4-yl)methylester derivatives as possible antimicrobial and antitubercular agents. Eur J Med Chem 49:172–182
Kempf DJ, Sham HL, Marsh KC, Flentge CA, Betebenner D, Green BE, McDonald E, Vasavanonda S, Saldivar A, Wideburg NE, Kati WM, Ruiz L, Zhao C, Fino L, Patterson J, Molla A, Plattner JJ, Norbeck DW (1998) Discovery of ritonavir, a potent inhibitor of HIV protease with high oral bioavailability and clinical efficacy. J Med Chem 41:602–617
Kennedy AJ, Mathews TP, Kharel Y, Field SD, Moyer ML, East JE, Houck JD, Lynch KR, Macdonald TL (2011) Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells. J Med Chem 54:3524–3548
Kesel AJ (2011) Broad-spectrum antiviral activity including human immunodeficiency and hepatitis C viruses mediated by a novel retinoid thiosemicarbazone derivative. Eur J Med Chem 46:1656–1664
Khalil AM, Berghot MA, Gouda MA (2009) Synthesis and antibacterial activity of some new thiazole and thiophenes derivatives. Eur J Med Chem 44:4434–4440
Khan KM, Karim A, Saied S, Ambreen N, Saleem M, Amyn A, Perveen S, Ahmad A, Choudharya MI (2012) Synthesis, antioxidant and carbonic anhydrase inhibitory potential of schiff bases of thiazoles. J Pharmacy Res 5:661–663
Kulkarni SS, Zou M-F, Cao J, Deschamps JR, Rodriguez AL, Conn PJ, Newman AH (2009) Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists. J Med Chem 52:3563–3575
Kumar GVS, Rajendraprasad Y, Mallikarjuna BP, Chandrashekar SM, Kistayya C (2010) Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents. Eur J Med Chem 45:2063–2074
Lakhan R, Sharma BP, Shukla BN (2000) Synthesis and antimicrobial activity of 1-aryl-2-amino-3-(4-arylthiazol-2-yl)/(benzothiazole-2-yl)guanidines. Farmaco 55:331–337
Lakshminarayana N, Prasad YR, Gharat L, Thomas A, Narayanan S, Raghurama A, Srinivasan CV, Gopalan B (2010) Synthesis and evaluation of some novel dibenzo[b,d]furan carboxylic acids as potential anti-diabetic agents. Eur J Med Chem 45:3709–3718
Lee J, Kim SJ, Choi H, Kim YH, Lim IT, Yang HM, Lee CS, Kang HR, Ahn SK, Moon SK, Kim DH, Lee S, Choi NS, Lee KJ (2010) Identification of CKD-516: apotent tubulin polymerization inhibitor with marked antitumor activity against murine and human solid tumors. J Med Chem 53:6337–6354
Lentzen G, Klinck R, Matassova N, Aboul-ela F, Murchie AI (2003) Structural basis for contrasting activities of ribosome binding thiazole antibiotics. Chem Biol 10:769–778
Li F, Zhu Q, Zhang Y, Feng Y, Leng Y, Zhang A (2010) Design, synthesis, and pharmacological evaluation of N-(4-mono and 4,5-disubstituted thiazol-2-yl)-2-aryl-3-(tetrahydro-2H-pyran-4-yl) propanamides as glucokinase activators. Bioorg Med Chem 18:3875–3884
Lin HM, Wang JC, Hu HS, Wu PS, Yang CC, Wu CP, Pu SY, Hsu TA, Jiaang WT, Chao YS, Chern JH, Yeh TK, Yueh A (2012) Resistance analysis and characterization of a thiazole analogue, BP008, as a potent hepatitis C virus NS5A inhibitor. Antimicrob Agents Chemother 56:44–53
Llinas-Brunet M, Bailey MD, Bolger G, Brochu C, Faucher AM, Ferland JM, Garneau M, Ghiro E, Gorys V, Grand-Maitre C, Halmos T, Lapeyre-Paquette N, Liard F, Poirier M, Rheaume M, Tsantrizos YS, Lamarre D (2004) Structure-activity study on a novel series of macrocyclic inhibitors of the hepatitis C virus NS3 protease leading to the discovery of BILN 2061. J Med Chem 47:1605–1608
Madsen P, Kodra JT, Behrens C, Nishimura E, Jeppesen CB, Pridal L, Andersen B, Knudsen LB, Valcarce-Aspegren C, Guldbrandt M, Christensen IT, Jorgensen AS, Ynddal L, Brand CL, Bagger MA, Lau J (2009) Human glucagon receptor antagonists with thiazole cores. A novel series with superior pharmacokinetic properties. J Med Chem 52:2989–3000
Makadia P, Shah SR, Pingali H, Zaware P, Patel D, Pola S, Thube B, Priyadarshini P, Suthar D, Shah M, Giri S, Trivedi C, Jain M, Patel P, Bahekar R (2011) Effect of structurally constrained oxime–ether linker on PPAR subtype selectivity: Discovery of a novel and potent series of PPAR-pan agonists. Bioorg Med Chem 19:771–782
Mallikarjuna BP, Sastry BS, Kumar GVS, Rajendraprasad Y, Chandrashekar SM, Sathisha K (2009) Synthesis of new 4-isopropylthiazole hydrazide analogs and some derived clubbed triazole, oxadiazole ring systems - A novel class of potential antibacterial, antifungal and antitubercular agents. Eur J Med Chem 44:4739–4746
Mao W, Ning M, Liu Z, Zhu Q, Leng Y, Zhang A (2012) Design, synthesis, and pharmacological evaluation of benzamide derivatives as glucokinase activators. Bioorg Med Chem 20:2982–2991
Mattmann ME, Yu H, Lin Z, Xu K, Huang X, Long S, Wu M, McManus OB, Engers DW, Le UM, Li M, Lindsley CW, Hopkins CR (2012) Identification of (R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide, ML277, as a novel, potent and selective Kv7.1 (KCNQ1) potassium channel activator. Bioorg Med Chem Lett 22:5936–5941
Mayhoub AS, Khaliq M, Botting C, Li Z, Kuhn RJ (2011) An investigation of phenylthiazole antiflaviviral agents. Bioorg Med Chem 19:3845–3854
Mjambili F, Njoroge M, Naran K, Kock CD, Smith PJ, Mizrahi V, Warner D, Chibale K (2014) Synthesis and biological evaluation of 2-aminothiazole derivatives as antimycobacterial and antiplasmodial agents. Bioorg Med Chem Lett 24:560–564
Moradi AV, Peyghan AA, Hashemian S, Baei MT (2012) Theoretical study of thiazole adsorption on the (6,0) zigzag single-walled boron nitride nanotube. Bull Korean Chem Soc 33:3285–3292
Moreno-Diaz H, Molina RV, Andrade RO, Coutin DD, Medina- Franco JL, Webster SP, Binnie M, Estrada-Soto S, Ibarra-Barajas M, Riverac IL, Vazqueza G (2008) Antidiabetic activity of N-(6-substituted-1,3-benzothiazol-2-yl)benzenesulfonamides. Bioorg Med Chem Lett 18:2871–2877
Morimoto Y, Nishikawa K, Ohashi M (1997) KB-R7785, a novel matrix metalloproteinase inhibitor, exerts its antidiabetic effect by inhibiting tumor necrosis factor-alpha production. Life Sci 61:795–803
Navarrete-Vazquez G, Morales-Vilchis MG, Estrada-Soto S, Ramirez-Espinosa JJ, Hidalgo-Figueroa S, Nava-Zuazo C, Tlahuext H, Leon-Rivera I, Medina-Franco JL, Lopez-Vallejo F, Webster SP, Binnie M, Ortiz-Andrade R, Moreno-Diaz H (2014) Synthesis of 2-{2-[(α/β-naphthalen-1-ylsulfonyl)amino]-1,3-thiazol-4-yl} acetamides with 11b-hydroxysteroid dehydrogenase inhibition and in combo antidiabetic activities. Eur J Med Chem 74:179–186
Nishikaku F, Koga Y (1993) Suppression of murine collagen-induced arthritis by treatment with a novel thiazole derivative, SM-8849. Immunopharmacology 25:65–74
Olaleye O, Raghunand TR, Bhat S, He J, Tyagi S, Lamichhane G, Gu P, Zhou J, Zhang Y, Grosset J, Bishai WR, Liu JO (2010) Methionine aminopeptidases from M. tuberculosis as novel antimycobacterial targets. Chem Biol 17:86–97
Ouimet N, Chan CC, Charleson S, Claveau, Gordon R, Guay D, Li C, Ouellet M, Percival DM, Riendeau D, Wong E, Zamboni R, Prasit P (1999) Substituted heterocyclic analogs as selective COX-2 inhibitors in the flosulide class. Bioorg Med Chem Lett 9:151–156
Palagiano F, Arenare L, Luraschi E, Caprariis P, Abignente E, D’Amico M, Filippelli W, Rossi F (1995) Research on heterocyclic compounds. Synthesis and SAR study of some imidazo[2,1-b]thiazole carboxylic and acetic acids with antiinflammatory and analgesic activities. Eur J Med Chem 30:901–909
Palaska E, Sahin G, Kelicen P, Durlu T, Altinok G (2002) Synthesis and anti-inflammatory activity of 1-acylthiosemicarbazides, 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazole-3-thiones. Farmaco 57:101–107
Park J, El-Gamal MI, Lee YS, Oh C (2011) New imidazo[2,1-b]thiazole derivatives: Synthesis, in vitro anticancer evaluation, and in silico studies. Eur J Med Chem 46:5769–5777
Patel RV, Patel PK, Kumari P, Rajani DP, Chikhalia KH (2012) Synthesis of benzimidazolyl-1,3,4-oxadiazol-2ylthio-N-phenyl (benzothiazolyl) acetamides as antibacterial, antifungal and antituberculosis agents. Eur J Med Chem 53:41–51
Patil PH, Patil L, Kadam VJ (2011) TNF-α: a potential therapeutic target for inflammatory bowel disease. Asian J Pharm Clin Res 4:158–166
Praly JP, Vida lS (2010) Inhibition of glycogen phosphorylase in the context of type 2 diabetes, with focus on recent inhibitors bound at the active site. Mini Rev Med Chem 10:1102–1126
Purandare A, Chen Z (2007) Inhibitors of protein arginine methyl transferases. US Patent 2007-0060589 A1, filled 20 Dec 2005, issued 15 Mar 2007
Raj KKV, Narayana B, Ashalatha BV, Kumari NS, Sarojini B (2007) Synthesis of some bioactive 2-bromo-5-methoxy-N′-[4-(aryl)-1,3-thiazol-2-yl]benzohydrazide derivatives. Eur J Med Chem 42:425–429
Reis RR, Azevedo EC, Souza MCBV, Ferreira VF, Montenegro RC, Araujo AJ, Pessoa C, Costa-Lotufo LV, Moraes MO, Filho JDBM, Souza AMT, Carvalho NC, Castro HC, Rodrigues CR, Vasconcelos TRA (2011) Synthesis and anticancer activities of some novel 2-(benzo[d]thiazol-2-yl)-8-substituted-2H-pyrazolo[4,3-c]quinolin-3(5H)-ones. Eur J Med Chem 46:1448–1452
Roppea JR, Wang B, Huang D, Tehrani L, Kamenecka T, Schweiger EJ, Anderson JJ, Brodkin J, Jiang X, Cramer M, Chung J, Reyes-Manalo G, Munoz B, Cosford NDP (2004) 5-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-2,3′-bipyridine: a highly potent, orally active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist with anxiolytic activity. Bioorg Med Chem Lett 14:3993–3996
Rostom SAF, El-Ashmawy IM, Razik HAA, Badr MH, Ashour HMA (2009) Design and synthesis of some thiazolyl and thiadiazolyl derivatives of antipyrine as potential non-acidic anti-inflammatory, analgesic and antimicrobial agents. Bioorg Med Chem 17:882–895
Ryabinin VA, Sinyakov AN, de Soultrait VR, Caumont A, Parissi V, Zakharova OD, Vasyutina EL, Yurchenko E, Bayandin R, Litvak S, Tarrago-Litvak L, Nevinsky GA (2000) Inhibition of HIV-1 integrase-catalysed reaction by new DNA minor groove ligands: the oligo-1,3-thiazolecarboxamide derivatives. Eur J Med Chem 35:989–1000
Salimon J, Salih N, Yousif E (2011) Synthesis, spectral and biological evaluation of some new heterocyclic derivatives incorporating dihydroanthracene moiety. J King Saud Univ Science 23:399–406
Sarojini BK, Krishna BG, Darshanraj CG, Bharath BR, Manjunatha H (2010) Synthesis, characterization, in vitro and molecular docking studies of new 2,5-dichloro thienyl substituted thiazole derivatives for antimicrobial properties. Eur J Med Chem 45:3490–3496
Sashidhara KV, K Rao B, Kushwaha P, Modukuri RK, Singh P, Soni I, Shukla PK, Chopra S, Pasupuleti M (2015) Novel chalcone–thiazole hybrids as potent inhibitors of drug resistant Staphylococcus aureus. Med Chem Lett 6:809–813
Scozzafava AI, Saramet I, Banciu MD, Supuran CT (2001) Carbonic anhydrase activity modulators: synthesis of inhibitors and activators incorporating 2-substituted-thiazol-4-yl-methyl scaffolds. J Enzyme Inhib 16:351–368
Secci D, Carradori S, Bizzarri B, Bolasco A, Ballario P, Patramani Z, Fragapane P, Vernarecci S, Canzonetta C, Filetici P (2014) Synthesis of a novel series of thiazole-based histone acetyltransferase inhibitors. Bioorg Med Chem 22:1680–1689
Shah A, Raj D (2015) Synthesis of some new 2′-amino-2-fluoro-5′-oxo-1′-(4-phenylthiazole-2-yl)-1′,4′,5′,6′,7′,8′-hexahydro-3,4′-biquinoline-3′-carbonitrile derivatives and biological evaluation as antimicrobial agents. J Saudi Chem Soc 19:73–82
Shah NK, Shah NM, Patel MP, Patel RG (2012) Synthesis, characterization and antimicrobial activity of some new biquinoline derivatives containing a thiazole moiety. Chin Chem Lett 23:454–457
Shao DZ, Lin M (2008) Platonin inhibits LPS-induced NF-kappaB by preventing activation of Akt and IKKbeta in human PBMC. Inflamm Res 57:601–606
Sharma PK, Sawhney SN (1997) Potent antiinflammatory 3-thiazole-4(5)-acetic acids of 1,2-benzoisothiazole. Bioorg Med Chem Lett 7:2427–2430
ShengFeng CUI, Yan W, JingSong LV, Guri L V DAMU, ChengHe ZHOU (2012) Recent advances in application of thiazole compounds. Sci Sin Chim 42:1105–1131
Shih MH, Ke FY (2004) Syntheses and evaluation of antioxidant activity of sydnonyl substituted thiazolidinone and thiazoline derivatives. Bioorg Med Chem 12:4633–4643
Shiradkar M, Kumar GVS, Dasari V, Tatikonda S, Akula KC, Shah R (2007a) Clubbed triazoles: a novel approach to antitubercular drugs. Eur J Med Chem 42:807–816
Shiradkar MR, Murahari KK, Gangadasu TS, Suresh T, Kalyan CA, Panchal D, Kaur R, Burange P, Ghogare J, Mokalec V, Raut M (2007b) Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-M. Tuberculosis agents. Bioorg Med Chem 15:3997–4008
Shirude PS, Madhavapeddi P, Naik M, Murugan K, Shinde V, Nandishaiah R, Bhat J, Kumar A, Hameed S, Holdgate G, Davies G, McMiken H, Hegde N, Ambady A, Venkatraman J, Panda M, Bandodkar B, Sambandamurthy VK, Read JA (2013) Methyl-thiazoles: a novel mode of inhibition with the potential to develop novel inhibitors targeting InhA in mycobacterium tuberculosis. J Med Chem 56:8533–8542
Siddiqui N, Ahsan W (2010) Triazole incorporated thiazoles as a new class of anticonvulsants: design, synthesis and in vivo screening. Eur J Med Chem 45:1536–1543
Simeon FG, Brown AK, Zoghbi SS, Patterson VM, Innis RB, Pike VW (2007) Synthesis and simple 18F-labeling of 3-fluoro-5-(2-(2-(fluoromethyl)thiazol-4-yl)ethynyl)benzonitrile as a high affinity radioligand for imaging monkey brain metabotropic glutamate subtype-5 receptors with positron emission tomography. J Med Chem 50:3256–3266
Simeon FG, Wendahl MT, Pike VW (2011) Syntheses of 2-amino and 2-halothiazole derivatives as high-affinity metabotropic glutamate receptor subtype 5 ligands and potential radioligands for in vivo imaging. J Med Chem 54:901–908
Sink R, Sosic I, Zivec M, Fernandez-Menendez R, Turk S, Pajk S, Alvarez-Gomez D, Lopez-Roman EM, Gonzales-Cortez C, Rullas-Triconado J, Angulo-Barturen I, Barros D, Ballell-Pages L, Young RJ, Encinas L, Gobec S (2015) Design, synthesis, and evaluation of new thiadiazole-based direct inhibitors of enoyl acyl carrier protein reductase (InhA) for the treatment of tuberculosis. J Med Chem 58:613–624
Smith B, Chang HH, Medda F, Gokhale V, Dietrich J, Davis A, Meuillet EJ, Hulme C (2012) Synthesis and biological activity of 2-aminothiazoles as novel inhibitors of PGE2 production in cells. Bioorg Med Chem Lett 22:3567–3570
Soares MIL, Brito AF, Laranjo M, Abrantes AM, Botelho MF, Paixao JA, Beja AM, Silva MR, Pinho e Melo TMVD (2010) Chiral 6-hydroxymethyl-1H,3H-pyrrolo[1,2-c]thiazoles: novel antitumor DNA monoalkylating agents. Eur J Med Chem 45:4676–4681
Soares MIL, Brito AF, Laranjo M, Paixao JA, Botelho MF, Melo TMVD Pe (2013) Chiral 6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles with anti-breast cancer properties. Eur J Med Chem 60:254–262
Sondhi SM, Singh N, Johar M, Kumar A (2005) Synthesis, anti-inflammatory and analgesic activities evaluation of some mono, bi and tricyclic pyrimidine derivatives. Bioorg Med Chem 13:6158–6166
Spector FC, Liang L, Giordano H, Sivaraja M, Peterson MG (1998) Inhibition of herpes simplex virus replication by a 2-amino thiazole via interactions with the helicase component of the UL5-UL8-UL52 complex. J Virol 72:6979–6987
Tafti AF, Foroumadi A, Tiwari R, Shirazi AN, Hangauer DG, Bu Y, Akbarzadeh T, Parang K, Shafiee A (2011) Thiazolyl N-benzyl-substituted acetamide derivatives: synthesis, Src kinase inhibitory and anticancer activities. Eur J Med Chem 46:4853–4858
Taher AT, Georgey HH, El-Subbagh H (2012) Novel 1,3,4-heterodiazole analogues: synthesis and in vitro antitumor activity. Eur J Med Chem 47:445–451
Tegginamath G, Kamble RR, Kattimani PP, Margankop SB (2011) Synthesis of 3-aryl-4-({2-[4-(6-substituted-coumarin-3-yl)-1,3-thiazol-2-yl]hydrazinylidene}methyl/ethyl)-sydnones using silica sulfuric acid and their antidiabetic, DNA cleavage activity. Arab J Chem. doi:10.1016/j.arabjc.2011.04.006
Thierbach G, Reichenbach H (1981) Myxothiazol, a new antibiotic interfering with respiration. Antimicrob Agents Chemother 19:504–507
Thompson RE, Jolliffe KA, Payne RJ (2011) Total synthesis of microcin B17 via a fragment condensation approach. Org Lett 13:680–683
Thore SN, Gupta SV, Baheti KG (2012) Synthesis and pharmacological evaluation of 5-methyl-2-phenylthiazole-4-substituted heteroazoles as a potential anti-inflammatory and analgesic agents. J Saudi Chem Soc (in press). doi:10.1016/j.jscs.2012.09.002
Ticha K, Mikulecka A, Mares P (2011) Behavioral consequences of the mGlu5 receptor antagonist MTEP in immature rats. Pharmacol Biochem Behav 99:619–625
Tozkoparan B, Ertan M, Kelicen P, Demirdamar R (1999) Synthesis and anti-inflammatory activities of some thiazolo[3,2-a]pyrimidine derivatives. Il Faramaco 54:588–593
Tripathi R, Nair NN (2013) Mechanism of acyl-enzyme complex formation from the Henry-Michaelis complex of class C β-lactamases with β-lactam antibiotics. J Am Chem Soc 135:14679–14690
Tuomanen E, Gilbert K, Tomasz A (1986) Modulation of bacteriolysis by cooperative effects of penicillin-binding proteins la and 3 in E. coli. Antimicrob Agents Chemother 30:659–663
Turan-Zitouni G, Kaplancikli ZA, Yildiz MT, Chevallet P, Kaya D (2005) Synthesis and antimicrobial activity of 4-phenyl/cyclohexyl-5-(1-phenoxyethyl)-3-[N-(2-thiazolyl)acetamide]thio-4H-1,2,4-triazole derivatives. Eur J Med Chem 40:607–613
Uzgoren-Baran A, Tel BC, Sarigol D, Ozturk EI, Kakayasi I, Okay G, Ertan M, Tozkoparan B (2012) Thiazolo[3,2-b]-1,2,4-triazole-5(6H)-one substituted with ibuprofen: novel non-steroidal anti-inflammatory agents with favorable gastrointestinal tolerance. Eur J Med Chem 57:398–406
Vijesh AM, Isloor AM, Prabhu V, Ahmad S, Malladi S (2010) Synthesis, characterization and anti-microbial studies of some novel 2,4-disubstituted thiazoles. Eur J Med Chem 45:5460–5464
Wang N-Y, Xu Y, Zuo W-Q, Xiao K-J, Liu L, Zeng X-X, You X-Y, Zhang L-D, Gao C, Liu Z-H, Ye T-H, Xia Y, Xiong Y, Song X-J, Lei Q, Peng C-T, Tang H, Yang S-Y, Wei Y-Q, Yu L-T (2015) Discovery of imidazo[2,1-b]thiazole HCV NS4B inhibitors exhibiting synergistic effect with other direct-acting antiviral agents. J Med Chem 58:2764–2778
Wang W, Yao D, Gu M, Fan M, Li J, Xing Y, Nan F (2005) Synthesis and biological evaluation of novel bisheterocycle-containing compounds as potential anti-influenza virus agents. Bioorg Med Chem Lett 15:5284–5287
Washburn WN (2009) Evolution of sodium glucose co-transporter 2 inhibitors as anti-diabetic agents. Expert Opin Ther Pat 19:1485–1499
Wei L, Wasilewski E, Chakka SK, Bello AM, Moscarello MA, Kotra LP (2013) Novel inhibitors of protein arginine deiminases with potential activity in multiple sclerosis animal model. J Med Chem 56:1715–1722
Woods KW, McCroskey RW, Michaelides MR, Wada CK, Hulkower KI, Bell RL (2001) Thiazole analogues of the NSAID indomethacin as selective COX-2 inhibitors. Bioorg Med Chem Lett 11:1325–1328
World Health Organization (2015a) Cancer fact sheet No. 297. www.who.int/mediacentre/factsheets/fs297/en/. Accessed 26 Feb 2015
World Health Organization (2015b) Tuberculosis fact sheet No. 104. http://www.who.int/mediacentre/factsheets/fs104/en/. Accessed 26 Feb 2015
Ye N, Neumeyer JL, Baldessarini RJ, Zhen X, Zhang A (2007) Recent progress in development of dopamine receptor subtype-selective agents: Potential therapeutics for neurological and psychiatric disorders. Chem Rev 107:274–302
Yea XY, Chen S, Zhang H, Locke KT, O’Malley K, Zhang L, Srivastava R, Miao B, Meyers D, Monshizadegan H, Search D, Grimm D, Zhang R, Lippy J, Twamley C, Muckelbauer JK, Chang C, An Y, Hosagrahara V, Zhang L, Yang T-J, Mukherjee R, Cheng PTW, Tino JA (2010) Synthesis and structure-activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARα selective activators - PPARα and PPARγ selectivity modulation. Bioorg Med Chem Lett 20:2933–2937
Yurttas L, Ozkay Y, Gencer HK, Acar U (2015) Synthesis of some new thiazole derivatives and their biological activity evaluation. J Chem. doi:10.1155/2015/464379
Zablotskaya A, Segal I, Geronikaki A, Tatiana E, Belyakov S, Petrova M, Shestakova I, Zvejniece L, Nikolajeva V (2013) Synthesis, physicochemical characterization, cytotoxicity, antimicrobial, anti-inflammatory and psychotropic activity of new N-[1,3-(benzo)thiazol-2-yl]-ω-[3,4-dihydroisoquinolin-2(1H)-yl]alkanamides. Eur J Med Chem 70:846–856
Zaharia V, Ignat A, Palibroda N, Ngameni B, Kuete V, Fokunang CN, Moungang ML, Ngadjui BT (2011) Synthesis of some p-toulenesulfonyl-hydrazinothiazoles and hydrazine-bis-thiazoles and their anticancer activity. Eur J Med Chem 45:5080–5085
Zhu J, Han L, Diao Y, Ren X, Xu M, Xu L, Li S, Li Q, Dong D, Huang J, Liu X, Zhao Z, Wang R, Zhu L, Xu Y, Qian X, Li Honglin (2015) Design, synthesis, X-ray crystallographic analysis, and biological evaluation of thiazole derivatives as potent and selective inhibitors of human dihydroorotate dehydrogenase. J Med Chem 58:1123–1139
Zitouni GT, Kaplanckl ZA, Ozdemir A (2010) Synthesis and antituberculosis activity of some N-pyridyl-N′-thiazolylhydrazine derivatives. Eur J Med Chem 45:2085–2088
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares that he has no conflict of interests.
Rights and permissions
About this article
Cite this article
Arora, P., Narang, R., Nayak, S.K. et al. 2,4-Disubstituted thiazoles as multitargated bioactive molecules. Med Chem Res 25, 1717–1743 (2016). https://doi.org/10.1007/s00044-016-1610-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-016-1610-2